microRNA-122down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1up-regulation

MicroRNAs and cardiac sarcoplasmic reticulum calcium ATPase-2 in human myocardial infarction: expression and bioinformatic analysis

(2012) Emanuela Boštjančič et al.   BMC GENOMICS

MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis

(2012) Wei-Chih Tsai et al.   JOURNAL OF CLINICAL INVESTIGATION

Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis

(2012) Jonel Trebicka et al.   JOURNAL OF HEPATOLOGY

Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling

(2011) Tetyana G. Voloshenyuk et al.   CYTOKINE

MicroRNA-1 and -499 Regulate Differentiation and Proliferation in Human-Derived Cardiomyocyte Progenitor Cells

(2010) Joost P.G. Sluijter et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Circulating microRNAs are new and sensitive biomarkers of myocardial infarction

(2010) Yuri D'Alessandra et al.   EUROPEAN HEART JOURNAL

microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors

(2010) A Geisler et al.   GENE THERAPY

Regulation of Myocardial Fibrosis by MicroRNAs

(2010) Johann Bauersachs   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C

(2010) Kazutoyo Morita et al.   LIVER INTERNATIONAL

Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes

(2010) Stine Jørgensen et al.   METHODS

Lysyl Oxidase Activity Is Dysregulated during Impaired Alveolarization of Mouse and Human Lungs

(2009) Arun Kumarasamy et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1  3' untranslated region confers risk for hepatocellular carcinoma

(2009) Y. Gao et al.   CARCINOGENESIS

Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines

(2009) Hongli Shan et al.   CARDIOVASCULAR RESEARCH

Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis

(2009) Frank Weidemann et al.   CIRCULATION

MicroRNA-133a Protects Against Myocardial Fibrosis and Modulates Electrical Repolarization Without Affecting Hypertrophy in Pressure-Overloaded Adult Hearts

(2009) Scot J. Matkovich et al.   CIRCULATION RESEARCH

Differential expression of microRNAs in mouse liver under aberrant energy metabolic status

(2009) Shengjie Li et al.   JOURNAL OF LIPID RESEARCH

Gender differences of echocardiographic and gene expression patterns in human pressure overload left ventricular hypertrophy

(2009) Ana V. Villar et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

A synthetic peptide from transforming growth factor- 1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats

(2008) N. Hermida et al.   CARDIOVASCULAR RESEARCH

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

(2008) et al.   CIRCULATION

miR-133 and miR-30 Regulate Connective Tissue Growth Factor

(2008) Rudy F. Duisters et al.   CIRCULATION RESEARCH

Impact of Treatment on Myocardial Lysyl Oxidase Expression and Collagen Cross-Linking in Patients With Heart Failure

(2008) Begoña López et al.   HYPERTENSION

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

(2008) Thomas Thum et al.   NATURE

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

(2008) E. van Rooij et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA